Europe's Cannabis Boom by the Numbers and Why Ziel Keeps It Safe
The European cannabis market is entering a period of explosive growth. Billions of euros are flowing into medical programs, cultivation hubs are scaling exports, and pilot legalization projects are underway. Yet behind the headlines and the numbers, one question remains central: how do we keep cannabis safe, compliant, and ready for international export?
That is where Ziel comes in. With advanced radio frequency decontamination technology, Ziel ensures that cannabis producers across Europe can meet EU-GMP standards, meet regulatory compliance, and preserve product quality while the market surges ahead.
The table below breaks down the numbers shaping Europe's cannabis industry in 2025, based on reporting from MMJ Daily.

Cannabis in Europe by the Numbers (2025 Estimates)
Country / Region | 2025 Market Value | 2024 Exports / Imports | Exports To |
---|---|---|---|
Germany | €670M | Imports: 72,000 kg | — |
United Kingdom | €300M | Imports: 15,500 kg | — |
Poland | €72M | — | — |
Portugal | ~€60M | Exports: 18,000+ kg | Germany (50%), Spain, Poland, UK, Australia |
Denmark | ~€45M | Exports: 7,000 kg | Germany |
Switzerland | €23.7M (pilots) | — | — |
Czech Republic | €20M | Exports: 1,300 kg | Germany |
What the Numbers Show
- Germany dominates as Europe’s largest medical cannabis market, with imports doubling in 2024.
- The UK continues rapid growth, supported by telehealth adoption and domestic cultivation.
- Poland, Portugal, and Denmark are smaller but strategically vital markets, supplying Germany and other EU states.
- Switzerland is pioneering adult-use pilots, already recording €23.7 million in sales.
- The Czech Republic has begun to scale exports, signaling its intent to grow as a supplier.
This growth represents more than opportunity. As volumes expand, the risks of contamination, recalls, and compliance failures also grow.


Ziel: Setting the Remediation Standard
Ziel's role in Europe's cannabis future is clear:
- Safety at scale: Eliminating harmful microbes without damaging cannabinoids or terpenes.
- Compliance made simple: Meet Pharmacopeia standards with flexible recipe settings
- Value protection: Preserving flower quality in markets where price competition is intensifying.
- Cross-border confidence: Giving regulators and importers assurance that products meet the highest quality standards, without having to register strains with AmRadV in Germany.
As Europe's cannabis market races toward multi-billion-euro growth, Ziel ensures the foundation is strong, safe, and scalable. Without it, the numbers are just numbers. With Ziel, they become a roadmap to a secure and thriving industry.